Quality of life during active treatment for pediatric acute lymphoblastic leukemia
โ Scribed by Lillian Sung; Rochelle Yanofsky; Robert J. Klaassen; David Dix; Sheila Pritchard; Naomi Winick; Sarah Alexander; Anne Klassen
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- French
- Weight
- 141 KB
- Volume
- 128
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The objectives of the study were to describe quality of life (QoL), identify predictors of worse QoL and examine QoL during different phases of active therapy for acute lymphoblastic leukemia (ALL). A multiinstitutional crossโsectional study was performed in children with ALL. We included children at least 2 months from diagnosis who were receiving treatment in first remission. Parents described QoL using the PedsQL 4.0 Generic Core Scales and the PedsQL 3.0 Acute Cancer Module. The 206 children on treatment for ALL had overall [median 62.5, 95% confidence interval (CI) 34.8โ94.4], physical (median 62.5, 95% CI 18.8โ100.0) and psychosocial (median 65.4, 95% CI 38.3โ94.2) summary scores that were one to two standard deviations lower than population norms. In highโrisk ALL, girls and older children had worse QoL. In standardโrisk ALL, those with lower household incomes and unmarried parents had worse QoL. QoL scores were generally constant across phases of ALL therapy. Children on therapy for ALL have lower QoL compared to healthy children. Age and gender predicted QoL in highโrisk ALL, whereas socioeconomics predicted QoL in standardโrisk ALL. Future efforts should focus on longitudinal studies that describe QoL over time within individual patients.
๐ SIMILAR VOLUMES
Background. Daily life motor skills of children with acute lymphoblastic leukemia (ALL) were studied during treatment using the Movement Assessment Battery for Children (Movement ABC). In addition, the possible relation with vincristine treatment was investigated. Procedure. Seventeen children treat
Due to concerns that antineoplastic therapy produces prolonged decrease in immune function, interferon treatment of chronic active hepatitis C (CAHC) has been used only at one year or longer after the end of cancer therapy. We report the experience of an 11-year-old who developed symptomatic CAHC at
## Background: Children treated for acute lymphoblastic leukemia (all) often complain about handwriting problems. ## Procedure: Using a computerized writing task, we have prospectively studied the processes necessary for the production of handwriting movements in 11 children (5-12 years old) duri
## Abstract ## Background Pneumocystis carinii pneumonia (PCP) is a wellknown risk among patients with deficient Tโcell function such as children treated for acute lymphoblastic leukemia (ALL). The purpose of this study was to estimate the risk for PCP during maintenance treament (MT) to identify